Geode Capital Management, LLC Sarepta Therapeutics, Inc. Transaction History
Geode Capital Management, LLC
- $1.26 Trillion
- Q4 2024
A detailed history of Geode Capital Management, LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,706,353 shares of SRPT stock, worth $184 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,706,353
Previous 1,696,354
0.59%
Holding current value
$184 Million
Previous $212 Million
2.08%
% of portfolio
0.02%
Previous 0.02%
Shares
31 transactions
Others Institutions Holding SRPT
# of Institutions
535Shares Held
87.4MCall Options Held
1.55MPut Options Held
1.35M-
Black Rock Inc. New York, NY10.3MShares$1.11 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.09MShares$978 Million0.02% of portfolio
-
Capital International Investors Los Angeles, CA8.7MShares$936 Million0.21% of portfolio
-
Janus Henderson Group PLC London, X04.33MShares$466 Million0.28% of portfolio
-
State Street Corp Boston, MA4.07MShares$438 Million0.02% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $9.43B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...